New task order, 3 year (base and 2 option years) for office of the commissioner (OC) research and policy support services
Ended Awarded Last action
- Contract number
- 75F40125F19012
- Awardee
-
Kaiva Strategies, LLC UEI HCWKVFGBPA64
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $304,734
Award facts
- Contract value 32% obligated
-
- $304,734.48 Current, with exercised options
- $941,896.32 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $304,734 |
About this award
The Food and Drug Administration (FDA) awarded a three-year task order to Kaiva Strategies, LLC for research and policy support services under the Professional, Administrative, and Consulting Services (PACS) Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The task order, effective through September 17, 2028, carries a ceiling value of $941,896.32 and was awarded on a labor-hours basis without a set-aside designation. Kaiva Strategies, a tribally-owned, minority-owned small business headquartered in Ivins, Utah, holds SBA Certified 8(a) Joint Venture status, along with HUBZone and small disadvantaged business certifications. The work will be performed in Silver Spring, Maryland, supporting the Office of the Commissioner with professional, administrative, and consulting expertise.
Kaiva Strategies brings substantial experience in supporting FDA missions, with a demonstrated track record delivering medical writing, scientific communication, regulatory support, and administrative services across multiple FDA centers and offices. The contractor holds a significant $100 million competitive 8(a) set-aside PACS IDIQ with the FDA, which serves as the vehicle for this task order issuance. This award reflects the agency's reliance on specialized consulting support to advance critical public health initiatives, leveraging Kaiva's expertise in regulatory affairs and scientific communication to strengthen policy development and research capabilities within the Office of the Commissioner.
Quick answers
Who was awarded contract 75F40125F19012?
75F40125F19012 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on September 18, 2025.
How much is contract 75F40125F19012 worth?
The government has obligated $304,734 on 75F40125F19012. Its potential value, with all options, is $941,896.
Is contract 75F40125F19012 an order under another contract?
Yes. 75F40125F19012 is a delivery order under 75F40123D00021, an indefinite delivery contract.
Was contract 75F40125F19012 competed?
The extent of competition for 75F40125F19012 was full and open competition after exclusion of sources.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award